Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production, and sale of functional ingredients and bio-based products in China and interna...
Chinese Infant Formula Ingredient Maker Cabio Slumps After Risk Warning
Nestlé's Chinese ARA Supplier Plunges After Swiss Firm Issues Global Recall of Baby Formula
12:11 ET CABIO präsentiert auf der Fi Europe 2025 in Paris Innovationen im Bereich Lebensphasenernährung und eröffnet gleichzeitig seinen neuen globalen Hauptsitz
CABIO: Cumulatively spent CNY 27.9213 million to repurchase 0.63% of the company's shares
CABIO: Third quarter net profit of 21.3942 million yuan, a year-on-year increase of 33.70%
CABIO expects a profit increase, with a projected year-on-year growth of 53.77% in net profit attributable to the parent company for the first three quarters